| Literature DB >> 20111694 |
Enrique Gómez-Barrena1, Francisco Medel, José Antonio Puértolas.
Abstract
Ultra-high molecular weight polyethylene (UHMWPE) remains the gold standard acetabular bearing material for hip arthroplasty. Its successful performance has shown consistent results and survivorship in total hip replacement (THR) above 85% after 15 years, with different patients, surgeons, or designs. As THR results have been challenged by wear, oxidation, and liner fracture, relevant research on the material properties in the past decade has led to the development and clinical introduction of highly crosslinked polyethylenes (HXLPE). More stress on the bearing (more active, overweighted, younger patients), and more variability in the implantation technique in different small and large Hospitals may further compromise the clinical performance for many patients. The long-term in vivo performance of these materials remains to be proven. Clinical and retrieval studies after more than 5 years of in vivo use with HXLPE in THR are reviewed and consistently show a substantial decrease in wear rate. Moreover, a second generation of improved polyethylenes is backed by in vitro data and awaits more clinical experience to confirm the experimental improvements. Also, new antioxidant, free radical scavengers, candidates and the reinforcement of polyethylene through composites are currently under basic research.Oxidation of polyethylene is today significantly reduced by present formulations, and this forgiving, affordable, and wellknown material is still reliable to meet today's higher requirements in total hip replacement.Entities:
Keywords: HXLPE; UHMWPE; cross-linked polyethylene; oxidation; polyethylene; total hip arthroplasty.
Year: 2009 PMID: 20111694 PMCID: PMC2812841 DOI: 10.2174/1874325000903010115
Source DB: PubMed Journal: Open Orthop J ISSN: 1874-3250
Summary of Significant Clinical Studies Confirming a Wear Rate Decrease with 1st Generation HXLPE in the Mid-Term Follow-Up
| Study | Design and Follow-up | HXLPE | HEAD | Follow-Up | Mean Wear Rate mm/yr (After Bedding-In) | Wear Rate Decrease |
|---|---|---|---|---|---|---|
| Dorr | Prospective, cohorts 37 hips/37 | Durasul 95 kGy, remelted | 28 mm CrCo | 5 years | 0.029 | 45% |
| D’Antonio | Retrospective, comparative 56 hips/53 | Crossfire 105 KGy, annealed | 28 mm CrCo | Mean 5 yr (min 4) | 0.036 | 72% |
| Engh | Prospective, randomized 208 hips | Marathon 50 kGy, remelted | 28 mm CrCo | 5.7 yr (4.1-7.2) | 0.01 | 95% |
| Olyslaegers | Case-control with historical 60 hips/20 | Longevity 100 KGy, remelted | 28 mm CrCo | XLPE 5.06 yr (52-69 mo), Std PE 5.1 yr (55-79) | 0.05 | 50% |
| García-Rey | Prospective, randomized 45 hips/45 | Durasul 95 kGy, remelted | 28 mm CrCo | 66.3 mo (60-92) | 0.006 | 84.3% |
| Geerdink | Randomized, double blind 17 hips/23 | Duration 30 KGy, annealed | 28 mm CrCo | Mean 8yr (7-9) | 0.088 | 38% |
Clinical Studies with 3D Analysis of Wear Rate with 1st Generation HXLPE
| Study | Design | HXLPE | Head | Follow-Up | Conclusions |
|---|---|---|---|---|---|
| Bragdon | Non-consecutive, non-randomized 30 hips | Longevity 100 kGy, remelted | 28mmCrCo (16 hips) | 3 years EFORT 09: 7-10yr | No diff 3D between 28 and 36mm |
| Röhrl | Retrospective, comparative 56 hips/53 | Crossfire 105 KGy, annealed | 28 mm CrCo | XLPE 6 yr, Std 5 yr | No wear rate progression at 6yr re oxidation |
| Digas | Prospective, randomized 56 hips | Durasul 95 kGy, remelted | 28 mm CrCo | 5 years | 0.001 |
| Digas | Prospective, randomized contralat control 32 hips/32 | Longevity 100 KGy, remelted | 28 mm CrCo | 5 years | 0.00 |
| Glyn-Jones | Prospective, doub-blind, rand, controlled 26 hips/25 | Longevity 100 KGy, remelted | 28 mm CrCo | 2 years | 0.06 mm/yr |